Bottom line
Is IJT a good fund? The bottom line
IJT is an index small-cap ETF from iShares.
Its expense ratio is 0.18% — about $18 a year on every $10,000 invested, cheaper than 95% of small-cap funds we track.
It returned +5.2% over one year, +5.4% a year over five years, +9.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $8.2 billion in net assets and 376 holdings, its largest position is BlackRock Funds III (8.0%) and the top 10 make up 18.3% of the portfolio.
The closest lower-cost alternative we found is VIOG (0.1%, 57% top-holdings overlap).
What stands out
- Low cost: cheaper than 95% of small-cap peers
- Broadly diversified (376 holdings)
Updated Nov 19, 2026
What IJT invests in
The iShares S&P Small-Cap 600 Growth ETF (the Fund ) seeks to track the investment results of an index composed of small-capitalization U.S. equities that exhibit growth characteristics.
The Fund seeks to track the investment results of the S&P SmallCap 600 Growth Index TM (the Underlying Index ), which measures the performance of the small-capitalization growth sector of the U.S. equity market. It is a subset of the S&P SmallCap 600 (the Parent Index ) and consists of those stocks in the Parent Index exhibiting the strongest growth characteristics, as determined by S&P Dow Jones Indices LLC (the Index Provider or SPDJI ), a subsidiary of S&P Global, Inc. The growth characteristics used by the Index Provider include three-year change in earnings per share over price per share, three-year sales-per-share growth rate and momentum (12-month percentage share price change). To the extent that earnings, sales and price data is not available for the above-listed time periods, the Index Provider will use shorter time periods in accordance with the Index Provider's methodology.…
From the fund's prospectus (filed Jul 27, 2026).
IJT performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| IJT | +5.2% | +5.4% | +9.6% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What IJT costs
On a $10,000 investment, IJT's 0.18% expense ratio costs about $18 a year. The prospectus estimates $230 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
IJT top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | BlackRock Funds III | 7.99% |
| 2 | FormFactor, Inc. | 1.36% |
| 3 | Viasat, Inc. | 1.33% |
| 4 | Argan, Inc. | 1.22% |
| 5 | BlackRock Funds III | 1.22% |
| 6 | BrightSpring Health Services, Inc. | 1.21% |
| 7 | Krystal Biotech, Inc. | 1.07% |
| 8 | ESCO Technologies, Inc. | 0.99% |
| 9 | Alkermes plc | 0.96% |
| 10 | Everus Construction Group, Inc. | 0.93% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 18.3% of the fund. See all top 25 holdings and asset mix →